Summary

Persistence Market Research has recently released a comprehensive report on the worldwide market for intravascular lithotripsy (IVL). The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global intravascular lithotripsy market from 2025 to 2032.

Key Insights:

• Intravascular Lithotripsy (IVL) Market Size (2025E): US$ 1,036.2 Million
• Projected Market Value (2032F): US$ 2,837.7 Million
• Global Market Growth Rate (CAGR 2025 to 2032): 15.5%

Intravascular Lithotripsy (IVL) Market - Report Scope:

Intravascular lithotripsy (IVL) is an advanced medical technology used to treat calcified vascular lesions by delivering acoustic pressure waves to break down calcium deposits within blood vessels. This minimally invasive procedure improves vessel compliance and facilitates optimal stent placement in patients with complex cardiovascular conditions. The IVL market caters to hospitals, specialty clinics, and ambulatory surgical centers, offering solutions for both coronary and peripheral artery diseases. Market growth is driven by the increasing prevalence of cardiovascular diseases, rising adoption of minimally invasive procedures, and technological advancements in interventional cardiology devices.

Market Growth Drivers:

The global intravascular lithotripsy market is propelled by several key factors, including the growing incidence of coronary artery disease and peripheral arterial disease due to aging populations and lifestyle-related risk factors. The increasing preference for minimally invasive procedures with improved safety and efficacy profiles is boosting the adoption of IVL technology. Technological advancements in lithotripsy systems, including enhanced catheter designs and improved energy delivery mechanisms, contribute to better clinical outcomes. Additionally, rising awareness among healthcare professionals and patients regarding advanced treatment options and the expansion of healthcare infrastructure in emerging markets further support market growth.

Market Restraints:

Despite promising growth prospects, the IVL market faces challenges related to high procedural costs and limited accessibility in low- and middle-income regions. The requirement for specialized training and expertise to perform IVL procedures may restrict adoption in smaller healthcare facilities. Regulatory approval processes for medical devices and stringent compliance requirements can delay product launches and increase development costs. Furthermore, competition from alternative treatment modalities, such as atherectomy devices and conventional angioplasty, may limit market penetration in certain clinical scenarios.

Market Opportunities:

The intravascular lithotripsy market presents significant growth opportunities driven by ongoing innovation and expanding clinical applications. Increasing research and development activities aimed at improving device efficiency and expanding indications beyond coronary and peripheral artery diseases create new growth avenues. Strategic collaborations between medical device manufacturers and healthcare providers can enhance market reach and adoption. Additionally, the growing focus on outpatient and ambulatory care settings, along with favorable reimbursement scenarios in developed markets, is expected to drive demand. Emerging markets also offer untapped potential due to improving healthcare access and rising investment in advanced medical technologies.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the intravascular lithotripsy market globally?
• Which product types and disease indications are driving IVL adoption across healthcare settings?
• How are technological advancements reshaping the competitive landscape of the IVL market?
• Who are the key players contributing to the intravascular lithotripsy market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global intravascular lithotripsy market?

Competitive Intelligence and Business Strategy:

Leading players in the global intravascular lithotripsy market, including Shockwave Medical Inc. (Johnson & Johnson Services, Inc.), Bolt Medical, Inc. (Boston Scientific), and Cardiovascular Systems, Inc. (Abbott), focus on innovation, strategic partnerships, and portfolio expansion to strengthen their market presence. These companies invest heavily in research and development to enhance device performance, safety, and clinical outcomes. Collaborations with healthcare institutions and regulatory bodies facilitate product approvals and market access. Additionally, expanding geographic presence and increasing awareness through clinical studies and physician training programs are key strategies adopted by market participants.

Key Companies Profiled:

• Shockwave® Medical Inc. (Johnson & Johnson Services, Inc.)
• Bolt Medical, Inc. (Boston Scientific)
• Cardiovascular Systems, Inc. (Abbott)
• AVS Pulse, Inc.
• Spectrumedics International
• MicroPort Scientific

Intravascular Lithotripsy (IVL) Market Research Segmentation:

By Product Type:

• Coronary Intravascular Lithotripsy Systems
• Peripheral Intravascular Lithotripsy Systems
• Accessories

By Disease Indication:

• Kidney Disorders
• Coronary Artery Disease
• Peripheral Arterial Disease
• Facilitated Vascular Access
• Others

By End-user:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others

By Region:

• North America
• Europe
• East Asia
• South Asia & Oceania
• Latin America
• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Intravascular Lithotripsy (IVL) Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Regulatory Landscape
3.2. Product Adoption Analysis
3.3. Current Portfolio and Pipeline
3.4. Value Chain Analysis
3.5. Key Deals and Mergers
3.6. PESTLE Analysis
3.7. Porter’s Five Force Analysis
4. Pricing Analysis, 2024
4.1. Key Factors Impacting Prices
4.2. Pricing Analysis by Product Type
4.3. Regional Prices and Product Preferences
5. Global Intravascular Lithotripsy (IVL) Market Outlook:
5.1. Key Highlights
5.1.1. Market Size (US$ Mn) and Y-o-Y Growth
5.1.2. Absolute $ Opportunity
5.2. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast
5.2.1. Historical Market Size (US$ Mn) and Volume (Units) Analysis, 2019-2024
5.2.2. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, 2025-2032
5.3. Global Intravascular Lithotripsy (IVL) Market Outlook: Product Type
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product Type, 2019-2024
5.3.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025-2032
5.3.3.1. Coronary Intravascular Lithotripsy Systems
5.3.3.2. Peripheral Intravascular Lithotripsy Systems
5.3.3.3. Accessories
5.3.4. Market Attractiveness Analysis: Product Type
5.4. Global Intravascular Lithotripsy (IVL) Market Outlook: Disease Indication
5.4.1. Introduction / Key Findings
5.4.2. Historical Market Size (US$ Mn) Analysis, By Disease Indication, 2019-2024
5.4.3. Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
5.4.3.1. Kidney Disorders
5.4.3.2. Coronary Artery Disease
5.4.3.3. Peripheral Arterial Disease
5.4.3.4. Facilitated Vascular Access
5.4.3.5. Others
5.4.4. Market Attractiveness Analysis: Disease Indication
5.5. Global Intravascular Lithotripsy (IVL) Market Outlook: End-user
5.5.1. Introduction / Key Findings
5.5.2. Historical Market Size (US$ Mn) Analysis, By End-user, 2019-2024
5.5.3. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
5.5.3.1. Hospitals
5.5.3.2. Specialty Clinics
5.5.3.3. Ambulatory Surgical Centers
5.5.3.4. Others
5.5.4. Market Attractiveness Analysis: End-user
6. Global Intravascular Lithotripsy (IVL) Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2019-2024
6.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia and Oceania
6.3.5. Latin America
6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region
7. North America Intravascular Lithotripsy (IVL) Market Outlook:
7.1. Key Highlights
7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
7.2.1. By Country
7.2.2. By Product Type
7.2.3. By Disease Indication
7.2.4. By End-user
7.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
7.3.1. U.S.
7.3.2. Canada
7.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025-2032
7.4.1. Coronary Intravascular Lithotripsy Systems
7.4.2. Peripheral Intravascular Lithotripsy Systems
7.4.3. Accessories
7.5. Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
7.5.1. Kidney Disorders
7.5.2. Coronary Artery Disease
7.5.3. Peripheral Arterial Disease
7.5.4. Facilitated Vascular Access
7.5.5. Others
7.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
7.6.1. Hospitals
7.6.2. Specialty Clinics
7.6.3. Ambulatory Surgical Centers
7.6.4. Others
7.7. Market Attractiveness Analysis
8. Europe Intravascular Lithotripsy (IVL) Market Outlook:
8.1. Key Highlights
8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
8.2.1. By Country
8.2.2. By Product Type
8.2.3. By Disease Indication
8.2.4. By End-user
8.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Russia
8.3.7. Turkey
8.3.8. Rest of Europe
8.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025-2032
8.4.1. Coronary Intravascular Lithotripsy Systems
8.4.2. Peripheral Intravascular Lithotripsy Systems
8.4.3. Accessories
8.5. Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
8.5.1. Kidney Disorders
8.5.2. Coronary Artery Disease
8.5.3. Peripheral Arterial Disease
8.5.4. Facilitated Vascular Access
8.5.5. Others
8.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
8.6.1. Hospitals
8.6.2. Specialty Clinics
8.6.3. Ambulatory Surgical Centers
8.6.4. Others
8.7. Market Attractiveness Analysis
9. East Asia Intravascular Lithotripsy (IVL) Market Outlook:
9.1. Key Highlights
9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
9.2.1. By Country
9.2.2. By Product Type
9.2.3. By Disease Indication
9.2.4. By End-user
9.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
9.3.1. China
9.3.2. Japan
9.3.3. South Korea
9.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025-2032
9.4.1. Coronary Intravascular Lithotripsy Systems
9.4.2. Peripheral Intravascular Lithotripsy Systems
9.4.3. Accessories
9.5. Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
9.5.1. Kidney Disorders
9.5.2. Coronary Artery Disease
9.5.3. Peripheral Arterial Disease
9.5.4. Facilitated Vascular Access
9.5.5. Others
9.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
9.6.1. Hospitals
9.6.2. Specialty Clinics
9.6.3. Ambulatory Surgical Centers
9.6.4. Others
9.7. Market Attractiveness Analysis
10. South Asia & Oceania Intravascular Lithotripsy (IVL) Market Outlook:
10.1. Key Highlights
10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
10.2.1. By Country
10.2.2. By Product Type
10.2.3. By Disease Indication
10.2.4. By End-user
10.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
10.3.1. India
10.3.2. Southeast Asia
10.3.3. ANZ
10.3.4. Rest of South Asia & Oceania
10.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025-2032
10.4.1. Coronary Intravascular Lithotripsy Systems
10.4.2. Peripheral Intravascular Lithotripsy Systems
10.4.3. Accessories
10.5. Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
10.5.1. Kidney Disorders
10.5.2. Coronary Artery Disease
10.5.3. Peripheral Arterial Disease
10.5.4. Facilitated Vascular Access
10.5.5. Others
10.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
10.6.1. Hospitals
10.6.2. Specialty Clinics
10.6.3. Ambulatory Surgical Centers
10.6.4. Others
10.7. Market Attractiveness Analysis
11. Latin America Intravascular Lithotripsy (IVL) Market Outlook:
11.1. Key Highlights
11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
11.2.1. By Country
11.2.2. By Product Type
11.2.3. By Disease Indication
11.2.4. By End-user
11.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025-2032
11.4.1. Coronary Intravascular Lithotripsy Systems
11.4.2. Peripheral Intravascular Lithotripsy Systems
11.4.3. Accessories
11.5. Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
11.5.1. Kidney Disorders
11.5.2. Coronary Artery Disease
11.5.3. Peripheral Arterial Disease
11.5.4. Facilitated Vascular Access
11.5.5. Others
11.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
11.6.1. Hospitals
11.6.2. Specialty Clinics
11.6.3. Ambulatory Surgical Centers
11.6.4. Others
11.7. Market Attractiveness Analysis
12. Middle East & Africa Intravascular Lithotripsy (IVL) Market Outlook:
12.1. Key Highlights
12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
12.2.1. By Country
12.2.2. By Product Type
12.2.3. By Disease Indication
12.2.4. By End-user
12.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
12.3.1. GCC Countries
12.3.2. Egypt
12.3.3. South Africa
12.3.4. Northern Africa
12.3.5. Rest of Middle East & Africa
12.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025-2032
12.4.1. Coronary Intravascular Lithotripsy Systems
12.4.2. Peripheral Intravascular Lithotripsy Systems
12.4.3. Accessories
12.5. Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
12.5.1. Kidney Disorders
12.5.2. Coronary Artery Disease
12.5.3. Peripheral Arterial Disease
12.5.4. Facilitated Vascular Access
12.5.5. Others
12.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
12.6.1. Hospitals
12.6.2. Specialty Clinics
12.6.3. Ambulatory Surgical Centers
12.6.4. Others
12.7. Market Attractiveness Analysis
13. Competition Landscape
13.1. Market Share Analysis, 2024
13.2. Market Structure
13.2.1. Competition Intensity Mapping By Market
13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
13.3.1. Shockwave® Medical Inc. (Johnson & Johnson Services, Inc.)
13.3.1.1. Overview
13.3.1.2. Segments and Products
13.3.1.3. Key Financials
13.3.1.4. Market Developments
13.3.1.5. Market Strategy
13.3.2. Bolt Medical, Inc. (Boston Scientific)
13.3.3. Cardiovascular Systems, Inc. (Abbott)
13.3.4. AVS Pulse, Inc.
13.3.5. Spectrumedics International
13.3.6. MicroPort Scientific
13.3.7. Elixir Medical
14. Appendix
14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations